{"id":169,"date":"2020-05-12T09:14:51","date_gmt":"2020-05-12T09:14:51","guid":{"rendered":"https:\/\/nclinnovations.org\/covid19monitor\/?p=169"},"modified":"2020-05-12T09:14:51","modified_gmt":"2020-05-12T09:14:51","slug":"11-may-2020-tocilizumab-reduced-icu-admissions-and-deaths","status":"publish","type":"post","link":"https:\/\/nclinnovations.org\/covid19monitor\/11-may-2020-tocilizumab-reduced-icu-admissions-and-deaths\/","title":{"rendered":"(11 May 2020) Tocilizumab- reduced ICU admissions and deaths"},"content":{"rendered":"<div class=\"boldgrid-section\">\n<div class=\"container\">\n<div class=\"row\">\n<div class=\"col-md-12 col-xs-12 col-sm-12\">\n<p>Tocilizumab therapy reduced intensive care unit admissions and\/ormortality in COVID-19 patients<\/p>\n<p><a href=\"https:\/\/doi.org\/doi:10.1016\/j.medmal.2020.05.001\">https:\/\/doi.org\/doi:10.1016\/j.medmal.2020.05.001<\/a><\/p>\n<p>In a retrospective case-control study with a small sample size, death and\/or ICU admissions were higher in patients without Tocilizumab (TCZ) than in the TCZ group (72% vs 25%, p=0.002). TCZ group patients less &nbsp;often required invasive mechanical ventilation than patients in the comparator group. None of the 20 TCZ-treated patients were hospitalized in the ICU. Finding enough ICU beds is highly challenging during the present COVID-19 pandemic TCZ could be key in the treatment of COVID-19 cases to reduce ICU admissions. &nbsp;<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Tocilizumab therapy reduced intensive care unit admissions and\/ormortality in COVID-19 patients https:\/\/doi.org\/doi:10.1016\/j.medmal.2020.05.001 In a retrospective case-control study with a small sample size, death and\/or ICU admissions were higher in patients without Tocilizumab (TCZ) than in the TCZ group (72% vs&hellip; <span class=\"read-more-span\"><a href=\"https:\/\/nclinnovations.org\/covid19monitor\/11-may-2020-tocilizumab-reduced-icu-admissions-and-deaths\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;(11 May 2020) Tocilizumab- reduced ICU admissions and deaths&#8221;<\/span> <span class=\"genericon genericon-next\"><\/span><\/a><\/span><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"bgseo_title":"","bgseo_description":"","bgseo_robots_index":"index","bgseo_robots_follow":"follow"},"categories":[4,18],"tags":[27],"_links":{"self":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/169"}],"collection":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/comments?post=169"}],"version-history":[{"count":1,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/169\/revisions"}],"predecessor-version":[{"id":170,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/169\/revisions\/170"}],"wp:attachment":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/media?parent=169"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/categories?post=169"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/tags?post=169"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}